Motion sickness is a common affliction that affects nearly half of the global population and poses challenges to comfortable travel experiences, necessitating diverse intervention strategies. Pharmacological interventions have shown promise but present limitations due to side effects. To date, there is no non- pharmacological alleviation method for motion sickness that has been proven effective in a large population. In this study, we developed a novel mindfulness brain-computer interface (mindfulness BCI) for alleviation of motion sickness. Thirty-one subjects who were susceptible to motion sickness participated in our experiments in a real-world car motion environment. The experimental results demonstrated that the proposed mindfulness BCI can effectively alleviate motion sickness symptoms, where more than 90% of subjects reported the effectiveness of the mindfulness BCI system and a significant reduction of Motion Sickness Susceptibility Questionnaire (MISC) scores was obtained when comparing the BCI-based meditation state with the resting state for the subjects (t <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">30</inf> =4.968, P<0.001). To the best of our knowledge, our mindfulness BCI is the first effective non- pharmacological alleviation method for motion sickness as demonstrated by a strict test.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: